AU7703700A - Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein - Google Patents
Treatment of lower urinary tract symptoms and pharmaceutical compositions for use thereinInfo
- Publication number
- AU7703700A AU7703700A AU77037/00A AU7703700A AU7703700A AU 7703700 A AU7703700 A AU 7703700A AU 77037/00 A AU77037/00 A AU 77037/00A AU 7703700 A AU7703700 A AU 7703700A AU 7703700 A AU7703700 A AU 7703700A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- pharmaceutical compositions
- urinary tract
- lower urinary
- tract symptoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15535799P | 1999-09-22 | 1999-09-22 | |
| US60155357 | 1999-09-22 | ||
| PCT/US2000/025534 WO2001021167A1 (en) | 1999-09-22 | 2000-09-18 | Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7703700A true AU7703700A (en) | 2001-04-24 |
Family
ID=22555118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU77037/00A Abandoned AU7703700A (en) | 1999-09-22 | 2000-09-18 | Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7703700A (en) |
| WO (1) | WO2001021167A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009227918B2 (en) * | 2000-02-09 | 2011-09-22 | Aspen Global Incorporated | Pharmaceutical combinations |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005503424A (en) * | 2001-09-27 | 2005-02-03 | ファルマシア アクチボラグ | Pharmaceutical composition for the treatment of urine diseases |
| EA008377B1 (en) * | 2002-04-24 | 2007-04-27 | Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг | Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention |
| EP1746998A1 (en) * | 2004-03-22 | 2007-01-31 | Ranbaxy Laboratories, Ltd. | Combination therapy for lower urinary tract symptoms |
| MX2007003949A (en) * | 2007-04-02 | 2009-02-25 | World Trade Imp Export Wtie Ag | Synergic pharmaceutical compositions consisting of a combination of a 5 a-reductase enzyme inhibitor and a 1 a- adrenergic receptor antagonist. |
| EP2363397A4 (en) * | 2008-11-07 | 2012-07-11 | Dainippon Sumitomo Pharma Co | Novel useful therapeutic agent for lower urinary tract symptom |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0760238T3 (en) * | 1994-05-18 | 2002-07-22 | Hisamitsu Pharmaceutical Co | Preparation that can be administered percutaneously for the treatment of urinary disorders |
-
2000
- 2000-09-18 AU AU77037/00A patent/AU7703700A/en not_active Abandoned
- 2000-09-18 WO PCT/US2000/025534 patent/WO2001021167A1/en active Application Filing
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009227918B2 (en) * | 2000-02-09 | 2011-09-22 | Aspen Global Incorporated | Pharmaceutical combinations |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001021167A8 (en) | 2001-09-07 |
| WO2001021167A1 (en) | 2001-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002324914A1 (en) | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith | |
| HU0100586D0 (en) | Pharmaceutical compositions treating lower urinary tract symptoms | |
| AU4300701A (en) | Methods and compositions for administration of therapeutic reagents | |
| EP1600168A3 (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorder | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| HU9802525D0 (en) | Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections | |
| AU2001275257A1 (en) | Methods and devices for the treatment of urinary incontinence | |
| EP1240136A4 (en) | Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease | |
| AU3469400A (en) | Pharmaceutical compositions for treatment of diseased tissues | |
| AU5326100A (en) | Pharmaceutical compositions and methods for use | |
| AU4340700A (en) | Methods and compositions for use in the treatment of hyperlipidemia | |
| AU2002248319A1 (en) | Pharmaceutical composition for the prevention and treatment of scar tissue | |
| AUPQ415899A0 (en) | Compositions for and methods of treatment of allergic diseases | |
| HK1067362A1 (en) | Heterocyclic compounds for use in the treatment ofdisorders of the urinary tract | |
| HUP0301460A3 (en) | Use of antiprogestins for producing pharmaceutical compositions for prohylaxis and treatment of hormone-dependent diseases | |
| HUP0303908A2 (en) | Use of selective cox-2 inhibitors for preparation of pharmaceutical composition for the treatment of urinary incontinence | |
| AU2300001A (en) | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease | |
| AUPR101600A0 (en) | Compositions and methods for diagnosis and treatment of cardiovascular disorders | |
| HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
| AU2001285683A1 (en) | Mild enrichment of foetal cells from peripheral blood and use thereof | |
| AU7703700A (en) | Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein | |
| AU1953701A (en) | Methods and compositions for treatment of inflammatory disease | |
| HUP0300860A3 (en) | Pharmaceutical compositions suitable for treatment of urinary dysfunction | |
| AU2001232345A1 (en) | Compositions for preventing and treating digestive diseases | |
| AU4228000A (en) | Methods and compositions for the treatment and prevention of lung disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |